Skip to main content
Rafael Holdings, Inc. logo

Rafael Holdings, Inc. — Investor Relations & Filings

Ticker · RFL ISIN · US75062C1009 US Professional, scientific and technical activities
Filings indexed 393 across all filing types
Latest filing 2025-12-11 Delisting Announcement
Country US United States of America
Listing US RFL

About Rafael Holdings, Inc.

https://rafaelholdings.com

Rafael Holdings, Inc. is a clinical-stage biotechnology company that invests in and develops therapies for difficult-to-treat diseases. The company holds interests in early-stage and clinical pharmaceutical entities, with a primary focus on novel cancer therapeutics aimed at improving and extending the lives of patients. Following a merger with Cyclo Therapeutics, Rafael Holdings is also advancing a potential breakthrough treatment for Niemann-Pick Type C1, a rare genetic disorder.

Recent filings

Filing Released Lang Actions
Delisting Announcement 2025
Delisting Announcement
2025-12-11 English
CURRENT REPORT
Regulatory Filings
2025-12-02 English
PROXY STATEMENT
Proxy Solicitation & Information Statement
2025-11-18 English
3
Director's Dealing
2025-10-31 English
ANNUAL REPORT
Annual Report FY 2025
2025-10-29 English
CURRENT REPORT
Regulatory Filings
2025-10-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.